Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

197
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
197
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

401
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
401
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

467
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
467

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Viable gut bacterial metrics associated with intestinal eubiosis and dysbiosis.

Gut microbes reports·2026
Same author

Focal Fatty Change After Total Pancreatectomy Mimics Hypervascular Liver Tumor.

The Kurume medical journal·2026
Same author

Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials.

Annals of hematology·2025
Same author

Exploratory Analysis of Practical Predictive Indices for the Efficacy of Mogamulizumab in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.

Hematological oncology·2025
Same author

Exploration of plasma factor profiles involved in tumor growth factors in non-small cell carcinoma patients with interstitial pneumonia.

Respiratory investigation·2025
Same author

A multicenter prospective study to determine the optimal range of lymph node dissection in pancreatic cancer surgery after neoadjuvant chemotherapy (LYMRIN-Trial): Project study by the Japan Pancreas Society and JON 2302-P.

PloS one·2025

Related Experiment Video

Updated: Sep 2, 2025

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

463

Non-invasive Monitoring of Pouchitis After Total Proctocolectomy Using Fecal Calprotectin Levels.

Tetsushi Kinugasa1, Keiichi Mitsuyama2, Kenta Murotani3

  • 1Department of Surgery, Department of Medicine, Kurume University School of Medicine.

The Kurume Medical Journal
|August 9, 2022
PubMed
Summary

Fecal calprotectin (FC) levels correlate with pouchitis disease activity and inflammation in ulcerative colitis patients after surgery. This suggests FC is a valuable marker for monitoring pouchitis post-total proctocolectomy.

Keywords:
PDAIcalprotectinfecespouchitisulcerative colitis

More Related Videos

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.1K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

281

Related Experiment Videos

Last Updated: Sep 2, 2025

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

463
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.1K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

281

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease Research
  • Surgical Outcomes

Background:

  • Fecal calprotectin (FC) is a key marker for ulcerative colitis (UC) activity.
  • Limited research exists on FC's role in pouchitis following total proctocolectomy (TP).
  • This study investigates FC in patients who underwent TP with ileal pouch-anal canal anastomosis (IPAA).

Purpose of the Study:

  • To assess the correlation between fecal calprotectin (FC) levels and clinical indicators in UC patients post-total proctocolectomy (TP).
  • To examine the relationship between FC levels and the Pouchitis Disease Activity Index (PDAI).
  • To determine if FC can serve as a marker for pouchitis after TP with IPAA.

Main Methods:

  • A cohort of 15 UC patients (8 male, 7 female, average age 46.5) undergoing TP with IPAA were studied.
  • Fecal calprotectin (FC) levels and endoscopic examinations were conducted over an average 68.3-month follow-up.
  • Clinical data, including white blood cell count, albumin, and C-reactive protein, were analyzed alongside PDAI scores.

Main Results:

  • The mean FC level was 418.69 μg/g; pouchitis was endoscopically confirmed in one patient (6.6%).
  • FC levels showed positive correlations with white blood cell count, albumin, C-reactive protein, and PDAI score (p<0.05).
  • Significantly higher median FC levels were observed in patients with pouchitis (111 mg/g) versus those without (16 mg/g) (p<0.05), with a strong correlation to endoscopic inflammation (p<0.00005).

Conclusions:

  • Fecal calprotectin (FC) levels are significantly correlated with the Pouchitis Disease Activity Index (PDAI) and endoscopic findings.
  • FC demonstrates a strong association with inflammatory markers and clinical indicators in UC patients post-TP.
  • FC is a potentially valuable non-invasive biomarker for assessing postoperative pouchitis and the overall condition of the ileal pouch following IPAA surgery for UC.